Photo credit: Health Canada
On Aug 24, 2021, Pharmascience Inc., issued a recall for their product - pms-PROGESTERONE 100 mg capsules 100-capsule bottles (DIN: 02476576, Lot: 1318593, Expiry: 10/2022).
The product has been recalled due to undeclared Peanuts allergen. According to Health Canada, "Pharmascience Inc. is recalling one lot (1318593, expiry 10/2022) of pms-PROGESTERONE 100 mg capsules because the bottles may contain Akorn 100 mg progesterone gelatin capsules in addition to or instead of the intended pms-PROGESTERONE 100 mg gelatin capsules.
The Akorn capsules contains peanut oil, an ingredient that is not listed on the label of pms-PROGESTERONE 100 mg capsules. Peanuts may cause life-threatening allergic reactions (anaphylaxis) in individuals with severe peanut allergies.
pms-PROGESTERONE is a prescription hormone drug used as a part of hormone replacement therapy for menopause in women.
The pms-PROGESTERONE 100 mg capsules are round and beige with “100” printed in black on the capsule, while the Akorn 100 mg progesterone capsules are round and pink with “AK” printed in black on the capsule.
The Pharmascience and Akorn capsules contain the same dose of the active ingredient, progesterone. Akorn 100 mg progesterone capsule is not authorized for sale in Canada, and therefore it has not been reviewed by Health Canada for its safety, efficacy, and quality.
Health Canada is monitoring the recall.
If you have severe peanut allergies, stop using your medication and return it to the pharmacy to get a replacement bottle.
If you do NOT have peanut allergies and if you find any Akorn progesterone capsules (pink marked with “AK”), return your bottle to the pharmacy for disposal of the Akorn progesterone doses and to receive replacement doses of pms-PROGESTERONE.
Consult a health care professional if you have used these products and have health concerns."
Additional information related to recall can be obtained by visiting Health Canada at One lot of pms-PROGESTERONE 100 mg capsules recalled because it may pose serious risks to individuals with severe peanut allergies - Canada.ca.
The recall is national and affects region(s) - Alberta, British Columbia, Manitoba, New Brunswick, Northwest Territories, Prince Edward Island, Ontario, Nunavut, Nova Scotia, Newfoundland and Labrador, Quebec, Saskatchewan, Yukon.
Report an error in this post by emailing us at email@example.com